Ophthalmologists must consider the cost-effectiveness of available treatment options for glaucoma and the impact this may have on patients, according to a speaker at the American Glaucoma Society meeting.
In the U.S., the cost of glaucoma medication was $2.7 billion per year by 2021, and while the U.S. accounts for 4.2% of the world’s population, it utilizes approximately 39% of glaucoma medication worldwide, Lama Al-Aswad, MD, MPH, of the University of Pennsylvania Perelman School of Medicine, said. These treatment regimens are often time-consuming for patients, leading to poor